Cargando…
Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485673/ https://www.ncbi.nlm.nih.gov/pubmed/34196168 http://dx.doi.org/10.3324/haematol.2021.278697 |
| _version_ | 1784577582562279424 |
|---|---|
| author | Niswander, Lisa M. Loftus, Joseph P Lainey, Élodie Caye-Eude, Aurélie Pondrom, Morgane Hottman, David A. Iacobucci, Ilaria Mullighan, Charles G. Jain, Nitin Konopleva, Marina Cavé, Hélène Baruchel, André Rohrlich, Pierre S. Tasian, Sarah K. |
| author_facet | Niswander, Lisa M. Loftus, Joseph P Lainey, Élodie Caye-Eude, Aurélie Pondrom, Morgane Hottman, David A. Iacobucci, Ilaria Mullighan, Charles G. Jain, Nitin Konopleva, Marina Cavé, Hélène Baruchel, André Rohrlich, Pierre S. Tasian, Sarah K. |
| author_sort | Niswander, Lisa M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8485673 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84856732021-10-18 Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia Niswander, Lisa M. Loftus, Joseph P Lainey, Élodie Caye-Eude, Aurélie Pondrom, Morgane Hottman, David A. Iacobucci, Ilaria Mullighan, Charles G. Jain, Nitin Konopleva, Marina Cavé, Hélène Baruchel, André Rohrlich, Pierre S. Tasian, Sarah K. Haematologica Letters to the Editor Fondazione Ferrata Storti 2021-07-01 /pmc/articles/PMC8485673/ /pubmed/34196168 http://dx.doi.org/10.3324/haematol.2021.278697 Text en Copyright© 2021 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Niswander, Lisa M. Loftus, Joseph P Lainey, Élodie Caye-Eude, Aurélie Pondrom, Morgane Hottman, David A. Iacobucci, Ilaria Mullighan, Charles G. Jain, Nitin Konopleva, Marina Cavé, Hélène Baruchel, André Rohrlich, Pierre S. Tasian, Sarah K. Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia |
| title | Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia |
| title_full | Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia |
| title_fullStr | Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia |
| title_full_unstemmed | Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia |
| title_short | Therapeutic potential of ruxolitinib and ponatinib in patients with EPOR-rearranged Philadelphia chromosome-like acute lymphoblastic leukemia |
| title_sort | therapeutic potential of ruxolitinib and ponatinib in patients with epor-rearranged philadelphia chromosome-like acute lymphoblastic leukemia |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485673/ https://www.ncbi.nlm.nih.gov/pubmed/34196168 http://dx.doi.org/10.3324/haematol.2021.278697 |
| work_keys_str_mv | AT niswanderlisam therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT loftusjosephp therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT laineyelodie therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT cayeeudeaurelie therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT pondrommorgane therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT hottmandavida therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT iacobucciilaria therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT mullighancharlesg therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT jainnitin therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT konoplevamarina therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT cavehelene therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT baruchelandre therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT rohrlichpierres therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia AT tasiansarahk therapeuticpotentialofruxolitinibandponatinibinpatientswitheporrearrangedphiladelphiachromosomelikeacutelymphoblasticleukemia |